Non-bacterial cystitis following treatment with toripalimab for alpha-fetoprotein-producing gastric adenocarcinoma: a case report - Top-Institutions - MDSpire

Non-bacterial cystitis following treatment with toripalimab for alpha-fetoprotein-producing gastric adenocarcinoma: a case report

  • By

  • Zhenpeng Li

  • Xiuxiu Yi

  • Jie Fu

  • Yan Liang

  • Sensen Zhang

  • Xv Yang

  • Zhonghai Du

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #3

    Sun Yat-sen University Cancer Center
    Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong

    Key Differentiators

    • Oncology

  • #4

    Shanghai Lung Cancer Center
    Shanghai Lung Cancer Center

    Shanghai, Shanghai

    Key Differentiators

    • Oncology

  • #5

    Shanxi Cancer Hospital
    Shanxi Cancer Hospital

    Taiyuan, Shanxi

    Key Differentiators

    • Oncology

Original Source(s)

Non-bacterial cystitis following treatment with toripalimab for alpha-fetoprotein-producing gastric adenocarcinoma: a case report

  • by Zhenpeng Li, Xiuxiu Yi, Jie Fu, Yan Liang, Sensen Zhang, Xv Yang, Zhonghai Du

  • July 14, 2026

Related Content

One-carbon metabolism in cancer immunity: T-cell fitness, epigenetic programming, and therapeutic opportunities

Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations

Precision medicine directed therapy enabling long-term survival in medulloblastoma: a case report